Renal Cell Carcinoma

(In the pipeline)

Select Format:

Select Volume:




Cat. No.




Renal Cell Carcinoma (RCC), also known as a gurnistical tumor, is a cancer of the kidney that arises from the proximal renal tubule; it is the most prevalent type of kidney cancer in adults. Anti-Renal Cell Carcinoma detects a glycoprotein in the brush border of the proximal renal tubule, and is a useful tool for diagnosis of primary renal cell carcinomas and metastatic renal cell carcinomas. Anti-RCC has also been used to label parathyroid adenoma and some breast carcinomas, however it does not react with nephroblastoma, oncocytoma, mesoblastic nephroma, transitional cell carcinoma, or angiomyolipoma.
  • References
    1. McGregor DK, et al. Am J Surg Pathol. 2001; 25:1485-92.
    2. Avery AK, et al. Am J Surg Pathol. 2000; 24:203-10.
    3. Gokden N, et al. Appl Immunohistochem Mol Morphol. 2003; 11:116-9.


Clone IHC657
Source Mouse Monoclonal
Positive Control Renal Cell Carcinoma
Dilution Range 1:100 - 1:400